140284 20240613151933.0 10.1016/j.neurol.2018.07.001 doi pmid:30098799 pmid 0035-3787 ISSN 2213-0004 ISSN altmetric:70398201 altmetric DZNE-2020-06606 English 610 Höglinger, G. U. P:(DE-2719)2811373 0 First author dzne New classification of tauopathies. Issy-les-Moulineaux 2018 Elsevier Masson print Crossref Elsevier BV 2018-11-01 article DRIVER Output Types/Journal article DataCite Journal Article journal journal PUB:(DE-HGF)16 1718284726_11707 PUB:(DE-HGF) Review Article ARTICLE BibTeX JOURNAL_ARTICLE ORCID Journal Article 0 EndNote Tauopathies are a group of neurodegenerative diseases characterized by pathological intracellular deposits of the protein tau. Isoform composition, morphology and anatomical distribution of cellular tau-immunoreactivities are defining distinct tauopathies as molecular pathological disease entities. The clinical spectrum of tauopathies includes syndromes with primary motor symptoms and with primary cognitive dysfunction. The traditional syndrome-based classification is currently being complemented by a molecular-pathological classification. While the syndrome-based classification is helpful to select symptomatic therapies, and to generate clinical working hypotheses about underlying etiologies, the molecular-pathological classification is most important for the development and application of molecularly tailored disease-modifying therapies. 344 - Clinical and Health Care Research (POF3-344) G:(DE-HGF)POF3-344 POF3-344 POF III 0 2018-11-01 Crossref https://www.elsevier.com/tdm/userlicense/1.0/ Dataset connected to CrossRef, PubMed, Humans MeSH Neurodegenerative Diseases: classification MeSH Neurodegenerative Diseases: genetics MeSH Supranuclear Palsy, Progressive: classification MeSH Supranuclear Palsy, Progressive: genetics MeSH Supranuclear Palsy, Progressive: physiopathology MeSH Tauopathies: classification MeSH Tauopathies: genetics MeSH Tauopathies: physiopathology MeSH Respondek, G. P:(DE-2719)2811600 1 dzne Kovacs, G. G. 2 10.1016/j.neurol.2018.07.001 : Elsevier BV, 2018-11-01 9 664-668 journal-article Crossref Revue Neurologique 174 2018 0035-3787 10.1016/j.neurol.2018.07.001 Vol. 174, no. 9, p. 664 - 668 PERI:(DE-600)2036356-4 9 174:9<664 - 668 664-668 Revue neurologique 174 2018 0035-3787 http://pub.dzne.de/record/140284/files/DZNE-2020-06606_Restricted.pdf http://pub.dzne.de/record/140284/files/DZNE-2020-06606_Restricted.pdf?subformat=pdfa pdfa VDB oai:pub.dzne.de:140284 Deutsches Zentrum für Neurodegenerative Erkrankungen I:(DE-588)1065079516 DZNE 0 P:(DE-2719)2811373 Deutsches Zentrum für Neurodegenerative Erkrankungen I:(DE-588)1065079516 DZNE 1 P:(DE-2719)2811600 DE-HGF Gesundheit Erkrankungen des Nervensystems G:(DE-HGF)POF3-340 G:(DE-HGF)POF3-344 G:(DE-HGF)POF3 G:(DE-HGF)POF3-300 G:(DE-HGF)POF Clinical and Health Care Research 0 2018 JCR StatID:(DE-HGF)0100 StatID REV NEUROL-FRANCE : 2021 2022-11-25 DBCoverage StatID:(DE-HGF)0200 StatID SCOPUS 2022-11-25 DBCoverage StatID:(DE-HGF)0300 StatID Medline 2022-11-25 DBCoverage StatID:(DE-HGF)0199 StatID Clarivate Analytics Master Journal List 2022-11-25 DBCoverage StatID:(DE-HGF)0150 StatID Web of Science Core Collection 2022-11-25 DBCoverage StatID:(DE-HGF)1050 StatID BIOSIS Previews 2022-11-25 DBCoverage StatID:(DE-HGF)1110 StatID Current Contents - Clinical Medicine 2022-11-25 DBCoverage StatID:(DE-HGF)1030 StatID Current Contents - Life Sciences 2022-11-25 IF < 5 StatID:(DE-HGF)9900 StatID 2022-11-25 I:(DE-2719)1110002 AG Höglinger 1 Translational Neurodegeneration 0 journal VDB I:(DE-2719)1110002 UNRESTRICTED